Richard A. Goldman
Thomas Jefferson University, Thomas Jefferson University Hospital
Papers
2
Total Citations
47
H-Index
2
About
Richard A. Goldman is a head and neck surgeon and researcher whose work focuses on improving outcomes for patients with oropharyngeal cancer, particularly through the use of transoral robotic surgery (TORS). His research bridges surgical oncology, patient risk stratification, and the impact of lifestyle factors on prognosis. In a highly cited 2020 study (38 citations), Goldman demonstrated that smoking significantly worsens disease-specific survival in patients with HPV-positive oropharyngeal cancer treated with TORS—challenging assumptions about the uniformly favorable prognosis of HPV-associated disease and underscoring the need for tailored treatment strategies. More recently, in 2024, he introduced the modified frailty index (mFI-5) as a predictive tool for complications and survival in the TORS population, using a national database to validate its utility. This work has important implications for preoperative counseling and patient selection. With a growing citation footprint and a focus on translating clinical data into actionable risk models, Goldman is contributing to a more nuanced, individualized approach to head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2